Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gamm

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Onkologie|June 1, 1986
Current results of a multicenter trial in multiple myelomaD Peest, H J Schmoll, I Schedel, et al.
Onkologie|February 1, 1988
[Alpha interferon in the therapy of hairy cell leukemia. Results of 3 prospective multicenter studies in West Germany]H Pralle, A Bartel, S Boedewadt-Radzun, et al.
Blut|January 1, 1990
MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphomaW Oster, T Forsthuber, H H Hennekeuser, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanomaA Lindemann, K Höffken, R E Schmidt, et al.
Cancer Treatment Reviews|June 1, 1989
A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignanciesA Lindemann, K Hoeffken, R E Schmidt, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Onkologie|June 1, 1986
Current results of a multicenter trial in multiple myelomaD Peest, H J Schmoll, I Schedel, et al.
Onkologie|February 1, 1988
[Alpha interferon in the therapy of hairy cell leukemia. Results of 3 prospective multicenter studies in West Germany]H Pralle, A Bartel, S Boedewadt-Radzun, et al.
Blut|January 1, 1990
MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphomaW Oster, T Forsthuber, H H Hennekeuser, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanomaA Lindemann, K Höffken, R E Schmidt, et al.
Cancer Treatment Reviews|June 1, 1989
A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignanciesA Lindemann, K Hoeffken, R E Schmidt, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Pageof 4